Results 31 to 40 of about 311,072 (299)

Angiotensin-(1–7) [PDF]

open access: yesHypertension, 2014
In the last decade, a substantial change in our understanding of the renin–angiotensin system (RAS) occurred.1,2 It is now clear that the circulating and tissue RAS are far more complex than previously anticipated. The modern concept of the RAS includes, in addition to the classical components (renin, angiotensin [Ang]-converting enzyme [ACE], Ang II ...
openaire   +2 more sources

Adenoviral delivery of angiotensin-(1-7) or angiotensin-(1-9) inhibits cardiomyocyte hypertrophy via the mas or angiotensin Type 2 receptor [PDF]

open access: yes, 2012
The counter-regulatory axis of the renin angiotensin system peptide angiotensin-(1-7) [Ang-(1-7)] has been identified as a potential therapeutic target in cardiac remodelling, acting via the mas receptor.
Nicklin Stuart A.   +11 more
core   +1 more source

Natriuretic action of angiotensin(1–7) [PDF]

open access: yesBritish Journal of Pharmacology, 1994
Evidence that angiotensin (1–7) (Ang(1–7)) is biologically active and can be synthesized by the kidney prompted us to examine its actions in the rat, isolated kidney. Ang(1–7) had three major effects producing, (1) a substantial natriuresis and diuresis, (2) an increase in urinary sodium concentration associated with a fall in potassium concentration ...
A M, DelliPizzi   +2 more
openaire   +2 more sources

Electronic sculpting of ligand-GPCR subtype selectivity:the case of angiotensin II [PDF]

open access: yes, 2014
GPCR subtypes possess distinct functional and pharmacological profiles, and thus development of subtype-selective ligands has immense therapeutic potential.
Pappas, Charalampos G.   +41 more
core   +1 more source

Effect of angiotensin receptor blockers and angiotensin converting enzyme 2 on plasma equilibrium angiotensin peptide concentrations in dogs with heart disease

open access: yesJournal of Veterinary Internal Medicine, 2021
Background The pathophysiology of heart failure involves maladaptive angiotensin peptides (APs) and enzymes, including angiotensin 2 (AT2) and angiotensin converting enzyme (ACE), as well as recently described alternative components, such as angiotensin ...
Éva Larouche‐Lebel   +3 more
doaj   +1 more source

Angiotensin II induces soluble fms-Like tyrosine kinase-1 release via calcineurin signaling pathway in pregnancy [PDF]

open access: yes, 2007
Maternal endothelial dysfunction in preeclampsia is associated with increased soluble fms-like tyrosine kinase-1 (sFlt-1), a circulating antagonist of vascular endothelial growth factor and placental growth factor.
Kellems, Rodney E.   +19 more
core   +1 more source

Angiotensin-(1–7) reduces α-synuclein aggregation by enhancing autophagic activity in Parkinson’s disease

open access: yesNeural Regeneration Research, 2022
Abnormal accumulation of α-synuclein contributes to the formation of Lewy bodies in the substantia nigra, which is considered the typical pathological hallmark of Parkinson’s disease.
Qing Gao   +6 more
doaj   +1 more source

Renin-Angiotensin System: A Review of Historical Perspectives

open access: yesGalician Medical Journal, 2023
The article is a review of publications concerning historical perspectives of the renin-angiotensin system. The discovery of its components is presented in chronological order, beginning with the initial identification of renin and proceeding to the ...
Olga Kovalyova   +2 more
doaj   +1 more source

Angiotensin-(1–7) exerts a protective action in a rat model of ventilator-induced diaphragmatic dysfunction

open access: yesIntensive Care Medicine Experimental, 2019
Background Ventilator-induced diaphragmatic dysfunction (VIDD) is a common event during mechanical ventilation (MV) leading to rapid muscular atrophy and contractile dysfunction. Recent data show that renin-angiotensin system is involved in diaphragmatic
Vanessa Zambelli   +7 more
doaj   +1 more source

The Role of Renin–Angiotensin System in Diabetic Cardiomyopathy: A Narrative Review

open access: yesLife, 2023
Diabetic cardiomyopathy refers to myocardial dysfunction in type 2 diabetes, but without the traditional cardiovascular risk factors or overt clinical atherosclerosis and valvular disease.
João Pedro Thimotheo Batista   +3 more
doaj   +1 more source

Home - About - Disclaimer - Privacy